Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06957028 · ClinicalTrials.gov registry record · NA
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
A NA study of Gestational Diabetes Mellitus in Pregnancy, sponsored by Jaeb Center for Health Research.
- Recruiting
- Registry status
- NA
- Development phase
- 6,000
- Enrollment target
- 10
- Study locations
NCT06957028: Recruiting NA study of Gestational Diabetes Mellitus in Pregnancy, sponsored by Jaeb Center for Health Research.
NCT06957028 is a NA study of Gestational Diabetes Mellitus in Pregnancy that is actively recruiting participants, run by Jaeb Center for Health Research. The registered enrollment target is 6,000 participants, above the 1,209-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (396% higher). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06957028, a NA study of Gestational Diabetes Mellitus in Pregnancy, is actively recruiting participants, sponsored by Jaeb Center for Health Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 6,000 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this clinical trial is to use continuous glucose monitoring (CGM) to quickly detect and manage high blood sugar in pregnant women, early in pregnancy. The main questions it aims to answer are: (1) any problems for the baby, such as being too large for their age, shoulder injuries (like broken bones), high bilirubin levels needing light treatment, low blood sugar, or needing to stay in the NICU; (2) any high blood pressure issues for the mother during pregnancy.
Primary Outcome
Composite endpoint of (1) neonatal complications of large for gestational age (LGA), shoulder dystocia (including humeral or clavicular fracture), elevated bilirubin requiring phototherapy, or neonatal intensive care unit (NICU) admission; or (2) maternal hypertensive disorder of pregnancy (HDP) .
Conditions Studied
Interventions
- OTHER Diabetes Treatment
- OTHER Usual Care Group
Study Locations (10)
Alabama
- University of Alabama at Birmingham - Birmingham
Florida
- University of Miami - Miami
Georgia
- Emory University - Decatur
Minnesota
- IDC at Park Nicollet - Saint Louis Park
New York
- Icahn School of Medicine at Mount Sinai - New York
Ohio
- Cleveland Clinic - Cleveland
Oregon
- Oregon Health & Science University - Portland
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2025-05-27 |
| Est. Completion | 2027-11-27 |
| Phase | NA |
What NCT06957028 shows while recruiting
NCT06957028 is an interventional study that assigns participants to a tested intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,209-participant average among 9 other Gestational Diabetes Mellitus in Pregnancy trials with a reported enrollment target (396% higher).
The record links to 1 condition, with Gestational Diabetes Mellitus in Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Treatment is the first listed.
NCT06957028 lists 10 locations in 10 states (Alabama, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT06957028 about?
NCT06957028 is a clinical study titled "CGM for the Early Detection and Management of Hyperglycemia in Pregnancy". The goal of this clinical trial is to use continuous glucose monitoring (CGM) to quickly detect and manage high blood sugar in pregnant women, early in pregnancy. The main questions it aims to answer are: (1) any problems for the baby, such as being too large for their age, shoulder injuries (like ...
What is the current status of trial NCT06957028?
This trial is currently recruiting. It is a NA study. The enrollment target is 6,000 participants. The study started on 2025-05-27. Estimated completion is 2027-11-27.
What conditions does trial NCT06957028 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus in Pregnancy.
What interventions are being tested in trial NCT06957028?
The interventions under investigation include: Diabetes Treatment (OTHER), Usual Care Group (OTHER).
Who is sponsoring clinical trial NCT06957028?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06957028 being conducted?
This trial has 10 study locations across Alabama, Florida, Georgia, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus in Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06957028's enrollment target sits among peer trials
6,000 2nd of 9 the highest of 9 other Gestational Diabetes Mellitus in Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes Mellitus in Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes
RECRUITING · NA
-
Early Detection of Gestational Diabetes Mellitus in Pregnancy
RECRUITING · NA
-
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
RECRUITING · NA
-
Mobile App Logging for Diabetes in Pregnancy
RECRUITING · NA
-
Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial
RECRUITING · NA
-
The CGMS in GDM Labor and Delivery Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI